The Times Australia
The Times World News

.

After buying health company Vectura, tobacco giant Philip Morris will profit from treating the illnesses its products create

  • Written by Kristin Carson-Chahhoud, Associate Research Professor, University of South Australia
After buying health company Vectura, tobacco giant Philip Morris will profit from treating the illnesses its products create

Cigarettes are the only legal consumer product that kill up to half of their users[1] when consumed exactly as the manufacturer intended. The diseases they cause cost Australia’s health system A$136.9 billion[2] a year.

Philip Morris International (PMI) is one of the global leaders[3] in the cigarette supply chain. But with steady declines[4] in cigarette sales over the past 20 years, tobacco companies such as Philip Morris are now attempting to market themselves[5] as health-care companies with visions for a “smoke-free future”.

One of the industry’s first moves was to manufacture[6] non-cigarette nicotine products, such as nicotine replacement therapy to help people quit smoking.

In the latest move to diversify its portfolio, Philip Morris has acquired British health-care company Vectura Group Plc, at a cost of[7] more than £1 billion (A$1.9 billion).

Vectura[8] specialises in manufacturing inhalation products such as commonly used inhalers (or puffers) and nebulisers that help people with asthma and lung disease to breathe.

Read more: Big Tobacco's decisive defeat on plain packaging laws won't stop its war against public health[9]

On August 12, the Vectura board announced[10] it “unanimously recommended the PMI offer” to shareholders, with the decision based on price and access to resources.

The Vectura board noted[11]:

[…] wider stakeholders could benefit from PMI’s significant financial resources and its intentions to increase research and development investment and to operate Vectura as an autonomous business unit that will form the backbone of its inhaled therapeutics business.

On September 15, the deal became official[12]. And so the problems begin.

Why Vectura?

In acquiring Vectura, Philip Morris will profit from[13] treating the very illnesses its products cause, as nebulisers are commonly prescribed for patients with tobacco-related lung disease.

Blue-spotted 'V' Vectura logo on a smartphone and in the background.
The Vectura takeover cost Philip Morris more than £1 billion. Shutterstock[14]

Philip Morris’s interest[15] in the company is to help it generate “[…] at least $1 billion in annual net revenues from Beyond Nicotine sources in 2025”. In other words, Philip Morris plans to expand development of electronic cigarettes and start profiting from other inhaled devices.

This is despite there being limited evidence[16] to support electronic cigarettes to help people quit smoking, but mounting evidence[17] showing damaging health effects.

If Philip Morris really wants to move “beyond nicotine”, it should stop its aggressive promotion and sale[18] of all tobacco products.

Why does it matter?

The consequences of Philip Morris’s acquisition of Vectura are far reaching, especially for the medical and research workforce fighting against respiratory disease. The Philip Morris takeover will have significant implications[19] for the sector.

Many public health organisations, medical professional bodies, universities, individual health professionals and researchers cannot and will not work with tobacco companies or their affiliates. This is in line with the World Health Organization’s Framework Convention on Tobacco Control[20].

This means researchers who would have received support from Vectura, or used their products to pioneer the next generation of inhaler therapies, will no longer be able to do this.

There will be conflicts of interest[21] prohibiting them from publishing their findings, collaborating on grants for new research, and presenting their work at conferences.

Read more: Medical journals refuse to publish tobacco-funded research[22]

This has already begun to happen, with pharmaceutical industry conferences such as the Drug Delivery to the Lungs Conference terminating Vectura’s sponsorship, forcing the company’s representative to stand down from its committee, and barring them[23] from participation[24].

Going forward, companies, health professionals and researchers now inadvertently linked to big tobacco through Vectura may be restricted from fully participating in the medical and scientific community. The European Respiratory Society, for example, excludes participation[25] from anyone with links to the tobacco industry in the past ten years.

The Pharmaceutical Benefits Scheme (PBS) will need to consider if it’s appropriate for Australian taxpayers to subsidise inhaler devices licensed to Vectura or, more truthfully, to big tobacco.

Many doctors will be looking for alternative devices to prescribe for their patients that do not contribute to Philip Morris’s or Vectura’s profits.

Meanwhile, people with lung disease are also likely to be reluctant to use devices linked to big tobacco[26].

Older man sits on the edge of his bed, breathing through a nebuliser mask.
Vectura makes nebulisers which help people with asthma and lung disease to breathe. Shutterstock[27]

But switching[28] from one inhaler to another comes with consequences, such as lower adherence and new side effects, causing poorer clinical outcomes.

There are also concerns Philip Morris’s takeover of Vectura could be used[29] to buy “a seat at the table” with health care policymakers and professionals, meaning they could have a say in the development of government policies.

The tobacco industry hasn’t changed

The tobacco industry remains one of the world’s most lethal[30]. And Philip Morris continues to undermine public health messages, while trying to disguise itself[31] as a health brand.

Yet Philip Morris’s company statutory regulations, which are the standards by which they undertake business, list[32] evidence-based actions to reduce smoking rates – such as strong health warnings on packets and smoking bans in public places – as “risk factors” for its business.

Philip Morris’s move into the health sector, reinforced with the latest acquisition of Vectura, should be met with equal measures of disgust and contempt.

References

  1. ^ kill up to half of their users (www.acosh.org)
  2. ^ A$136.9 billion (ndri.curtin.edu.au)
  3. ^ global leaders (www.statista.com)
  4. ^ steady declines (www.aihw.gov.au)
  5. ^ attempting to market themselves (www.pmi.com)
  6. ^ manufacture (tobaccotactics.org)
  7. ^ at a cost of (www.bmj.com)
  8. ^ Vectura (www.vectura.com)
  9. ^ Big Tobacco's decisive defeat on plain packaging laws won't stop its war against public health (theconversation.com)
  10. ^ Vectura board announced (www.vectura.com)
  11. ^ board noted (www.vectura.com)
  12. ^ deal became official (www.vectura.com)
  13. ^ profit from (tobaccofreeportfolios.org)
  14. ^ Shutterstock (www.shutterstock.com)
  15. ^ interest (pmidotcom3-restricted-prd.s3.amazonaws.com)
  16. ^ limited evidence (onlinelibrary.wiley.com)
  17. ^ mounting evidence (www.thoracic.org.au)
  18. ^ aggressive promotion and sale (www.tobaccofreekids.org)
  19. ^ significant implications (tobaccofreeportfolios.org)
  20. ^ Framework Convention on Tobacco Control (www.phrp.com.au)
  21. ^ conflicts of interest (tobaccofreeportfolios.org)
  22. ^ Medical journals refuse to publish tobacco-funded research (theconversation.com)
  23. ^ barring them (www.thetimes.co.uk)
  24. ^ participation (tobaccoreporter.com)
  25. ^ excludes participation (d197for5662m48.cloudfront.net)
  26. ^ devices linked to big tobacco (d197for5662m48.cloudfront.net)
  27. ^ Shutterstock (www.shutterstock.com)
  28. ^ switching (www.ncbi.nlm.nih.gov)
  29. ^ could be used (www.bmj.com)
  30. ^ most lethal (www.phrp.com.au)
  31. ^ trying to disguise itself (www.ncbi.nlm.nih.gov)
  32. ^ list (www.sec.gov)

Read more https://theconversation.com/after-buying-health-company-vectura-tobacco-giant-philip-morris-will-profit-from-treating-the-illnesses-its-products-create-168564

Times Magazine

Headless CMS in Digital Twins and 3D Product Experiences

Image by freepik As the metaverse becomes more advanced and accessible, it's clear that multiple sectors will use digital twins and 3D product experiences to visualize, connect, and streamline efforts better. A digital twin is a virtual replica of ...

The Decline of Hyper-Casual: How Mid-Core Mobile Games Took Over in 2025

In recent years, the mobile gaming landscape has undergone a significant transformation, with mid-core mobile games emerging as the dominant force in app stores by 2025. This shift is underpinned by changing user habits and evolving monetization tr...

Understanding ITIL 4 and PRINCE2 Project Management Synergy

Key Highlights ITIL 4 focuses on IT service management, emphasising continual improvement and value creation through modern digital transformation approaches. PRINCE2 project management supports systematic planning and execution of projects wit...

What AI Adoption Means for the Future of Workplace Risk Management

Image by freepik As industrial operations become more complex and fast-paced, the risks faced by workers and employers alike continue to grow. Traditional safety models—reliant on manual oversight, reactive investigations, and standardised checklist...

From Beach Bops to Alpine Anthems: Your Sonos Survival Guide for a Long Weekend Escape

Alright, fellow adventurers and relaxation enthusiasts! So, you've packed your bags, charged your devices, and mentally prepared for that glorious King's Birthday long weekend. But hold on, are you really ready? Because a true long weekend warrior kn...

Effective Commercial Pest Control Solutions for a Safer Workplace

Keeping a workplace clean, safe, and free from pests is essential for maintaining productivity, protecting employee health, and upholding a company's reputation. Pests pose health risks, can cause structural damage, and can lead to serious legal an...

The Times Features

The Role of Your GP in Creating a Chronic Disease Management Plan That Works

Living with a long-term condition, whether that is diabetes, asthma, arthritis or heart disease, means making hundreds of small decisions every day. You plan your diet against m...

Troubleshooting Flickering Lights: A Comprehensive Guide for Homeowners

Image by rawpixel.com on Freepik Effectively addressing flickering lights in your home is more than just a matter of convenience; it's a pivotal aspect of both home safety and en...

My shins hurt after running. Could it be shin splints?

If you’ve started running for the first time, started again after a break, or your workout is more intense, you might have felt it. A dull, nagging ache down your shins after...

Metal Roof Replacement Cost Per Square Metre in 2025: A Comprehensive Guide for Australian Homeowners

In recent years, the trend of installing metal roofs has surged across Australia. With their reputation for being both robust and visually appealing, it's easy to understand thei...

Why You’re Always Adjusting Your Bra — and What to Do Instead

Image by freepik It starts with a gentle tug, then a subtle shift, and before you know it, you're adjusting your bra again — in the middle of work, at dinner, even on the couch. I...

How to Tell If Your Eyes Are Working Harder Than They Should Be

Image by freepik Most of us take our vision for granted—until it starts to let us down. Whether it's squinting at your phone, rubbing your eyes at the end of the day, or feeling ...